Business
Avenir Wellness Solutions to Present at Investor Summit Group's Q4 Conference
Sherman Oaks, California--(Newsfile Corp. - November 10, 2022) - Avenir Wellness Solutions, Inc. (f/k/a CURE Pharmaceutical Holding Corp.) (OTCQB: CURR) today
About this update from Currenc Group Inc.
[{"type":"text","content":"Sherman Oaks, California--(Newsfile Corp. - November 10, 2022) - Avenir Wellness Solutions, Inc. (f/k/a CURE Pharmaceutical Holding Corp.) (OTCQB: CURR) today announced that CEO Nancy Duitch will be attending the Q4 Investor Summit live in NYC at the Sheraton Times Square. The Company's presentation scheduled for 2:00pm EST on Monday, November 14, 2022, will highlight the Company's recent asset sale that provided non-dilutive capital to the Company and the related name change as well as articulate the Company's current technology incubator strategy and its goal of becoming a house of quality brands through organic efforts as well as through M&A. Ms. Duitch will also be conducting one-on-one meetings with investors during the conference.\nEvent: Q4 Investor Summit\nDate: November 14-15 2022\nPresentation: November 14th at 2:00 P.M. ET\nLocation: Sheraton New York Times Square Hotel, 811 7th Avenue, W 53rd St, New York, NY 10019\nWebcast: https://us06web.zoom.us/webinar/register/WN_cM48fmVuRhaILp36J8C-NQ\n\n1x1s will be available for qualified investors\nThe conference is completely complimentary to qualified investors. Please register at Complimentary Investor Registration\n\nAbout Avenir Wellness Solutions\nAvenir Wellness Solutions, Inc. (f/k/a Cure Pharmaceutical Holding Corp.) is a broad platform technology company that develops proprietary drug, nutraceutical and topical delivery systems and currently holds fifteen patents. The technology offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and patient/consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new innovative technology that will be part of its incubator strategy while continuing to develop, produce and market in the wellness and beauty sectors through its wholly-owned subsidiary The Sera Labs, Inc. utilizing cutting edge technology and high-quality products that use science-backed, proprietary formulations. Sera Labs products are sold Direct to Consumer with a subscribe and save option, as well as in major national drug, grocery chains, and mass retailers.\nInvestor Relations Contact:\nHanover International Inc. - (760) 564-7400 - [email protected]\nAbout Investor Summit Group\nThe Investor Summit (formerly MicroCap Conference...